Clinical Trials Browser

Adenoviridae Infections, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02894944 2019-09-12

Theragene

Phase 1 Completed

9 enrolled

Gastrointestinal

Adenoviridae Infections, Pancreatic Neoplasms

NCT03029871 2019-08-13

NSCLC

Phase 1 Withdrawn

Thoracic

Adenoviridae Infections, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00372320 2018-09-11

Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer

Phase 1 Completed

17 enrolled

Head & Neck

Adenoviridae Infections, Head and Neck Neoplasms, Xerostomia

NCT02654938 2017-09-20

Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer

Phase 1 Completed

32 enrolled

Genitourinary

Adenoviridae Infections, Prostatic Neoplasms

NCT01864759 2017-08-29

Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma

Phase 1 Completed

14 enrolled

Dermatologic

Adenoviridae Infections, Melanoma, Neoplasm Metastasis

NCT01070797 2014-09-04

VIRAGE

Phase 1 Completed

10 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT00625430 2011-07-11

FP253-GDEPT

Phase 1 Unknown

18 enrolled

Genitourinary

Adenoviridae Infections, Prostatic Neoplasms

NCT00109655 2008-10-03

Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure

Phase 1 Unknown

75 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Adenoviridae Infections, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT00262327 2006-06-20

Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor

Phase 1 Unknown

20 enrolled

Adenoviridae Infections, Neoplasms

Clinical Trials

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

TUNIMO

A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors

TETRAVI

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

CEDAR

R-MVST Cells for Treatment of Viral Infections

Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma

Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer

Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma

AdUP

ACE

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer

Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections

Theragene

NSCLC

Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer

Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer

Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma

VIRAGE

FP253-GDEPT

Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure

Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor